Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19<blockquote>吉利德的瑞德西韦在重症COVID-19风险较高的合并症患者中显示出一致的疗效</blockquote>
Gilead Sciences Inc announced full results from a Phase 3 study of a three-day course of Veklury (re